Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human metagenome

ABSTRACT: Alterations of Vaginal Microbiota by Lactobacillus supporsitories in patients with recurrent urinary tract infection

PROVIDER: PRJDB11068 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR267136_1.fastq.gz	Fastqsanger.gz
	DRR267136_2.fastq.gz	Fastqsanger.gz
	DRR267137_1.fastq.gz	Fastqsanger.gz
	DRR267137_2.fastq.gz	Fastqsanger.gz
	DRR267138_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 148

Similar Datasets

Human Urinary Proteome in Vesicoureteral Reflux

Project description:Vesicoureteral reflux (VUR) is a common pediatric condition that predisposes children to renal damage after urinary tract infection (UTI). We profiled the urinary proteome of VUR patients with recurrent UTI and renal scarring to identify potential biomarkers characterizing this condition. Urine was obtained from 22 age-matched controls and 22 patients with low grade VUR (1-3 out of 5), renal scarring, and history of recurrent UTI. Proteins extracted from these samples were analyzed by mass spectrometry for protein identification and quantitation for comparison.

2018-10-05 | PXD010469 | Pride

Project description:Microbial Dysregulation in Recurrent Urinary Tract Infection: Gut and Vaginal Microbiome Profiling

| PRJNA1133690 | ENA

Klebsiella pneumoniae

Project description:Case study of recurrent urinary tract infection

| PRJNA589891 | ENA

Project description:The urinary microbiome in patients with refractory urge incontinence and recurrent urinary tract infection

| PRJNA487122 | ENA

human metagenome

Project description:Alterations of Vaginal Microbiota by Lactobacillus Tablets in Postmenopausal Women

| PRJDB10783 | ENA

Human CVL LC-MSMS to Elucidate Functions in Bacterial Vaginosis

Project description:Bacterial vaginosis (BV) is a common state of the vaginal microbiota characterized by increased bacterial diversity and decreased Lactobacillus abundance. Using untargeted metaproteomics, we identified host and bacterial proteins in a set of 29 cervicovaginal lavage samples from people with and without BV which revealed functions and interactions that likely contribute to BV.

2025-03-07 | PXD051980 | Pride

NAPRUTI microbiota

Project description:Intestinal microbiota and urinary tract infection

| PRJEB13868 | ENA

Gene expression profile in patients inoculated with E. coli 83972

Project description:Urinary tract infections (UTIs) constitute a highly relevant model of microbial adaptation, in which the contrasting effects of pathogens and commensals on host tissues are clearly displayed. While virulent Escherichia coli cause severe, potentially life-threatening disease by breaking the inertia of the mucosal barrier and infecting the kidneys, the most common outcome of bacteriuria is an asymptomatic carrier state resembling commensalism at other mucosal sites. It remains unclear if the lack of destructive inflammation merely reflects low virulence or if carrier strains actively inhibit disease associated responses in the host. To address this question, we examined the effects of asymptomatic bacterial carriage on host gene expression. Therapeutic urinary tract inoculation with the prototype ABU strain E. coli 83972 is a safe alternative approach in patients with therapy-resistant recurrent UTI. The strain establishes persistent bacteriuria, protecting patients against super-infection with more virulent strains. Using this protocol, we examined if the establishment of asymptomatic bacterial carriage alters host gene expression. After antibiotic treatment to remove prior infection, patients were inoculated with E. coli 83972 through a catheter. Blood samples were obtained before and 24 h after inoculation.

2013-02-23 | E-GEOD-43838 | biostudies-arrayexpress

Vaginal Lactobacillus fatty acid response mechanisms reveal a metabolite-targeted strategy for bacterial vaginosis treatment

Project description:Bacterial vaginosis (BV), a common syndrome characterized by Lactobacillus-deficient vaginal microbiota, is associated with adverse health outcomes. BV often recurs after standard antibiotic therapy in part because antibiotics promote microbiota dominance by Lactobacillus iners instead of Lactobacillus crispatus, which has more beneficial health associations. Strategies to promote L. crispatus and inhibit L. iners are thus needed. We show that oleic acid (OA) and similar long-chain fatty acids simultaneously inhibit L. iners and enhance L. crispatus growth. These phenotypes require OA-inducible genes conserved in L. crispatus and related lactobacilli, including an oleate hydratase (ohyA) and putative fatty acid efflux pump (farE). FarE mediates OA resistance, while OhyA is robustly active in the vaginal microbiota and enhances bacterial fitness by biochemically sequestering OA in a derivative form only ohyA-harboring organisms can exploit. OA promotes L. crispatus dominance more effectively than antibiotics in an in vitro BV model, suggesting a metabolite-based treatment approach.

2024-06-26 | GSE270628 | GEO

Project description:microbial community from the human urine, collected from recurrent urinary tract infection patients

| PRJNA1234800 | ENA